Indication

Acute repetitive seizures

Acute repetitive seizures, also referred to as seizure clusters, are a recognized neurological manifestation characterized by intermittent, stereotypic episodes of increased seizure frequency occurring over a short time frame—typically minutes to 48 hours—in patients with epilepsy. Read more about Acute repetitive seizures

28 drugs 24 manufacturers

Advertisement

Drugs that treat it

Common Acute repetitive seizures therapies.

Showing 10–18 of 28 drugs

DIAZEPAM

ANTICONVULSANTS·ACUTE REPETITIVE SEIZURES
OCEANSIDE PHARM

DIAZEPAM

BENZODIAZEPINES·TETANUS·+9
NEPHRON/OF

DIAZEPAM

BENZODIAZEPINES·TETANUS·+9
DR.REDDY'S LAB

DIAZEPAM

BENZODIAZEPINES·TETANUS·+9
ALEMBIC PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Acute repetitive seizures preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute repetitive seizures.

Acute repetitive seizures, also referred to as seizure clusters, are a recognized neurological manifestation characterized by intermittent, stereotypic episodes of increased seizure frequency occurring over a short time frame—typically minutes to 48 hours—in patients with epilepsy.

Affecting the central nervous system across pediatric and adult populations, these episodes represent a distinct departure from an individual’s typical baseline seizure pattern and frequency.

Clinically, they involve closely grouped focal or generalized seizures with a return to consciousness or baseline neurological status between events.

Without timely recognition and intervention, this clinical state carries a substantial risk of progressing into prolonged seizures or life-threatening status epilepticus.

Personalize your experience

Follow Acute repetitive seizures and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it